Do patents impede the provision of genetic tests in Australia?

Australian Health Review

Volumn 37, Issue 3, 2013, Pages 281-285

  Nicol, Dianne ^a   Liddicoat, John ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880478036     PISSN: 01565788     EISSN: 14498944     Source Type: Journal    
DOI: 10.1071/AH13029     Document Type: Article

References (27)

1. Jensen K, Murray F. Intellectual property landscape of the human genome. Science 2005; 310: 239-40. doi:10.1126/science.1120014
2. Holman CM. Will gene patents impede whole genome sequencing? Deconstructing the myth that 20% of the human genome is patented. IP Theory 2011; 2(1): Article 1.
3. Huys I, Berthels N, Matthijs G, Van Overwalle G. Legal uncertainty in the area of genetic diagnostic testing. Nat Biotechnol 2009; 27: 903-9. doi:10.1038/nbt1009-903
4. Gold ER, Carbone J. Myriad Genetics: In the eye of the policy storm. Genet Med 2010; 12: S39-70. doi:10.1097/GIM.0b013e3181d72661
5. Cho MK, Illangasekare S, Weaver MA, Leonard DGB, Merz JF. Effect of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3-8. doi:10.1016/S1525-1578(10)60444-8
6. Merz JF, Kriss DG, Leonard DGB, Cho MK. Diagnostic testing fails the test. Nature 2002; 415: 577-9. doi:10.1038/415577a
7. US Secretary's Advisory Committee on Genetics. Health and society (SACGHS), gene patents and licensing practices and their impact on patient access to genetic tests. Washington DC: 2010. Available at http://oba.od.nih. gov/SACGHS/sacghs-documents.html#GHSDOC-011 [verified 15 April 2013]
8. Cook-Deegan R, Conley JM, Evans JP, Vorhaus D. The next controversy in genetic testing: Clinical data as trade secrets? Eur J Hum Genet 2012; doi:10.1038/ejhg.2012.217
9. Nicol D. Balancing innovation and access to healthcare through the patent system-an Australian perspective. Community Genet 2005; 8: 228-34. doi:10.1159/000087960
10. Gaisser S, Hopkins MM, Liddell K, Zika E, Ibarreta D. The phantom menace of gene patents. Nature 2009; 458: 407-8. doi:10.1038/458407a
11. Hawkins N. The impact of human gene patents on genetic testing in the United Kingdom. Genet Med 2011; 13: 320-4. doi:10.1097/GIM.0b013e3181fc50bc
12. Australian Senate Community Affairs Committee. Report on gene patents. Canberra: Parliament of Australia; 2010. Available at http://www.aph.gov.au/ Parliamentary-Business/Committees/Senate-Commit tees?url=clac-ctte/completed- inquiries/2010-13/gene-patents-43/index. htm [Verified 15 April 2013]
13. Berg JS, Khoury MJ, Evans JP. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet Med 2011; 13: 499-504. doi:10.1097/GIM.0b013e318220aaba
14. Price WN. Unblocked future: Why gene patents won't hinder whole genome sequencing and personalized medicine. Cardozo Law Rev 2012; 33: 1601-31.
15. Holman CM. Debunking the myth that whole-genome sequencing infringes thousands of gene patents. Nat Biotechnol 2012; 30: 240-4. doi:10.1038/nbt.2146
16. Ridley A, Nicol D. Is there still a place for gene patents in Australia? Implications of recent US and European case law. J Law Med 2011; 19: 282-99.
17. Patent Amendment (Human Genes and Biological Materials) Bill 2010. Available at http://www.comlaw.gov.au/Details/C2011B00012 [Verified 18 April 2013]
18. Australian Senate Legal and Constitutional Affairs Legislation Committee. Patent Amendment (Human Genes and Biological Materials) Bill 2010. Canberra; Parliament of Australia; 2011.
19. Nicol D, Liddicoat J. Legislating to exclude gene patents: Difficult and unhelpful or useful and feasible. J Law Inf Sci 2012; 22: 32-54.
20. Van Overwalle G, van Zimmeren E, Verbeure B, Matthijs G. Models for facilitating access to patents on genetic inventions. Nat Rev Genet 2006; 7: 143-54. doi:10.1038/nrg1765
21. Productivity Commission. Compulsory licensing of patents, draft report. Canberra: Australian Government; 2012.
22. Nicol D, Nielsen J. Patents and medical biotechnology: An empirical analysis of issues facing the Australian industry. Occasional Paper No. 6. Hobart: Centre for Law and Genetics; 2003.
23. Nicol D, Nielsen J. Australian medical biotechnology: Navigating a complex patent landscape. Eur Intellect Prop Rev 2005; 27: 313-8.
24. Australian Law Reform Commission. Genes and ingenuity: Gene patenting and human health. Report 99. Canberra:Commonwealth of Australia; 2004. Available at http://www.austlii.edu.au/au/other/alrc/publications/reports/99/ [Verified 18 April 2013]
25. Australian Government. Response to Senate Community Affairs Refer ences Committee gene patents report. Available at http://www.ipaustral ia.gov.au/pdfs/Australian-Government-response-senate-committee-gen e-patents-report.doc [Verified 18 April 2013]
26. Smith S. Push for ban on gene patents. Lateline, 14 May 2012. Available at http://www.abc.net.au/lateline/content/2012/s3502732.htm [Verified 18 April 2013]
27. Nielsen J, Nicol D. Whither patent use without authorisation in Australia. Fed Law Rev 2008; 36: 333-64.